RATIONALE: Studying individuals who are enrolled in phase I clinical trials may help to improve the way in which clinical trials are conducted. PURPOSE: This clinical trial is studying patients' personality traits, reasons for participating in the trial, and understanding of their medical situation, prognosis, and risks and benefits of participating in a phase I trial.
OBJECTIVES: * Determine the range of personality traits of patients enrolled in a phase I clinical trial. * Determine these patients' understanding of their medical situation and prognosis. * Determine these patients' understanding of risks and benefits of phase I clinical trials. * Determine these patients' reasons for participating in a phase I clinical trial. * Determine the risk/benefit trade-offs of these patients. * Determine the existential outlook of these patients. * Determine the information gathering nature of these patients. OUTLINE: This is a multicenter study. Before beginning phase I clinical trial treatment, patients complete a survey over 30-45 minutes administered by an interviewer. Patients then self-administer the Temperament and Character Inventory assessment over 30 minutes. PROJECTED ACCRUAL: Approximately 250 patients will be accrued for this study within 6 months.
Study Type
INTERVENTIONAL
Masking
NONE
Enrollment
250
Robert H. Lurie Comprehensive Cancer Center at Northwestern University
Chicago, Illinois, United States
Warren Grant Magnuson Clinical Center - NCI Clinical Trials Referral Office
Bethesda, Maryland, United States
Fox Chase Cancer Center - Philadelphia
Philadelphia, Pennsylvania, United States
M. D. Anderson Cancer Center at University of Texas
Houston, Texas, United States
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
Cancer Therapy and Research Center
San Antonio, Texas, United States